Zynerba Pharmaceuticals Inc
(NASDAQ : ZYNE)

( )
ZYNE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-0.90%91.0018.6%$133.32m
AMRNAmarin Corporation Plc Sponsored ADR
1.55%17.702.0%$105.80m
JAZZJazz Pharmaceuticals Plc
-1.24%125.212.2%$71.98m
SAGESAGE Therapeutics, Inc.
-1.00%146.189.5%$71.87m
PRGOPerrigo Co. Plc
-1.29%48.316.8%$60.83m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.18%145.656.3%$57.44m
CTLTCatalent Inc
-0.54%42.562.4%$42.29m
PTLAPortola Pharmaceuticals, Inc.
0.67%30.157.7%$41.62m
ICLRICON Plc
-2.58%142.154.1%$34.76m
HZNPHorizon Pharma plc
-1.39%21.247.4%$29.63m
CORTCorcept Therapeutics Incorporated.
-2.03%11.095.5%$29.56m
UTHRUnited Therapeutics Corporation
-0.74%117.0214.4%$29.11m
MDCOMedicines Company
0.04%23.9021.8%$27.14m
AERIAerie Pharmaceuticals, Inc.
-2.30%38.706.9%$26.52m
MNKMallinckrodt Plc
-3.30%20.5221.1%$24.45m

Company Profile

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.